Vimarsana
Biggest News Aggregation in the World

Authorized Prescriber Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Authorized Prescriber Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Authorized Prescriber Program Today - Breaking & Trending Today

PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney - Vimarsana News

PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney

Utilizing Advice from the UK’s Medicines and Healthcare Regulatory Agency, PharmAla to move forward on Clinical TrialsVANCOUVER, British Columbia, July 20, 2023 -- PharmAla Biotech Holdings Inc. ...

Cortexa Makes First Drug Order for Australian Commercial Market - Vimarsana News

Cortexa Makes First Drug Order for Australian Commercial Market

PharmAla’s Australian Joint Venture Orders First Shipment of MDMA and Psilocybin for Commercial UseVANCOUVER, British Columbia, July 04, 2023 -- PharmAla Biotech Holdings Inc. , a...

Cortexa Makes First Drug Order for Australian Commercial - Vimarsana News

Cortexa Makes First Drug Order for Australian Commercial

PharmAla’s Australian Joint Venture Orders First Shipment of MDMA and Psilocybin for Commercial Use...

USFDA Approves LaNeo MDMA for Clinical Trial Use in the - Vimarsana News

USFDA Approves LaNeo MDMA for Clinical Trial Use in the

Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech...

USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States - Vimarsana News

USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States

Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 -- PharmAla Biotech Holdings Inc. , a biotechnology company focused on the... | June 10, 2023